A. Taylor

发表

Polycystic ovarian syndrome--relationship to epilepsy and antiepileptic drug therapy.

J. Hall, A. Taylor, H. Joffe, 2001, The Journal of clinical endocrinology and metabolism.

On the Association Between Valproate and Polycystic Ovary Syndrome

B. Pedersen, P. Genton, M. Sauer, 2001, Epilepsia.

Is GnRH Reduced at the Midcycle Surge in the Human?

C. Welt, Julie A. Smith, K. Martin, 1998, Neuroendocrinology.

Gonadotropins and Gonadal Steroid Feedback

W. Crowley, C. Welt, Julie A. Smith, 1998 .

The Physiology of the Human Midcycle Gonadotropin Surge

W. Crowley, C. Welt, K. Martin, 2000 .

Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

R. Norman, H. Escobar-Morreale, E. Diamanti-Kandarakis, 2006, The Journal of clinical endocrinology and metabolism.

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

R. Norman, H. Escobar-Morreale, E. Diamanti-Kandarakis, 2009, Fertility and sterility.

Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.

D. Schoenfeld, G. Lambert-Messerlian, W. Crowley, 1997, The Journal of clinical endocrinology and metabolism.

Homologous in vitro bioassay for follicle-stimulating hormone (FSH) reveals increased FSH biological signal during the mid- to late luteal phase of the human menstrual cycle.

W. Crowley, P. Sluss, C. Albanese, 1996, The Journal of clinical endocrinology and metabolism.

Impact of binge eating on metabolic and leptin dynamics in normal young women.

A. Taylor, E. Anderson, J. Hubbard, 1999, The Journal of clinical endocrinology and metabolism.

Polycystic ovary syndrome.

A. Taylor, Ann E. Taylor, A. Taylor, 1998, Endocrinology and metabolism clinics of North America.

Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.

D. Schoenfeld, J. Hall, J. Adams, 1997, The Journal of clinical endocrinology and metabolism.

Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.

W. Crowley, J. Adams, Ann E. Taylor, 2004, The Journal of clinical endocrinology and metabolism.

Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis.

C. Welt, A. Schneyer, J. Adams, 2005, The Journal of clinical endocrinology and metabolism.

Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations.

C. Welt, A. Schneyer, A. Taylor, 2000, The Journal of clinical endocrinology and metabolism.

Follistatin Physiology and Potential Mechanisms of Action in the Human

W. Crowley, P. Sluss, F. Pralong, 1997 .

Effects of short‐term hormone replacement on serum leptin levels in postmenopausal women

J. L. Sharpless, E. Anderson, Ann E. Taylor, 1999, Clinical endocrinology.

Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men

F. Greenway, Steven R Smith, D. Fryburg, 2010, Obesity.

A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone.

I. Huhtaniemi, R. Clayton, B. Fauser, 1999, The Journal of clinical endocrinology and metabolism.

Systemic adversities of ovarian failure.

Ann E. Taylor, A. Taylor, 2001 .

A Putative Relationship between Valproic Acid and Polycystic Ovarian Syndrome: Implications for Treatment of Women with Seizure and Bipolar Disorders

R. Baldessarini, L. Cohen, Janet E Hall, 2003, Harvard review of psychiatry.

Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay.

G. Lambert-Messerlian, W. Crowley, P. Sluss, 1994, The Journal of clinical endocrinology and metabolism.

Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotropic hypogonadism or premature ovarian failure.

C. Welt, J. Adams, Ann E. Taylor, 2005, The Journal of clinical endocrinology and metabolism.

Female reproductive aging is marked by decreased secretion of dimeric inhibin.

C. Welt, J. Hall, D. J. McNicholl, 1999, The Journal of clinical endocrinology and metabolism.

Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels.

C. Welt, K. Martin, A. Falorni, 2005, The Journal of clinical endocrinology and metabolism.

Systemic Adversities of Ovarian Failure

Ann E. Taylor, A. Taylor, 2001, Journal of the Society for Gynecologic Investigation.

Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome

W. Crowley, J. Hall, F. Hayes, 1998, Journal of endocrinological investigation.

Insulin-lowering medications in polycystic ovary syndrome.

A. Taylor, A. Taylor, 2000, Obstetrics and gynecology clinics of North America.

Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women.

D. Schoenfeld, W. Crowley, J. Hall, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women.

W. Crowley, J. Hall, A. Taylor, 1995, The Journal of clinical endocrinology and metabolism.

Effects of Steady-State Lasofoxifene on Cyp2D6- and Cyp2E1-Mediated Metabolism

R. Obach, R. Walsky, M. Gardner, 2006, The Annals of pharmacotherapy.

Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.

J. Hall, F. Hayes, A. Taylor, 1998, The Journal of clinical endocrinology and metabolism.

Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications.

A. Taylor, A. Taylor, 1998, American journal of obstetrics and gynecology.

ANDROGEN EXCESS SOCIETY GUIDELINE SYNDROME AS A PREDOMINANTLY HYPERANDROGENIC SYNDROME: AN POSITION STATEMENT: CRITERIA FOR DEFINING POLYCYSTIC OVARY

R. Norman, H. Escobar-Morreale, E. Diamanti-Kandarakis, 2006 .

Clinical Evaluation of Polycystic Ovary Syndrome

Ann E. Taylor, A. Taylor, 2007 .

Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone.

C. Welt, Janet E Hall, K. Martin, 2002, The Journal of clinical endocrinology and metabolism.

Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles.

G. Lambert-Messerlian, C. Welt, A. Schneyer, 2001, The Journal of clinical endocrinology and metabolism.